A new study led by Lund University in Sweden has solved a years-old mystery: which patients with aggressive breast cancer are helped by a targeted cancer treatment that had been under development but was shelved.
Tarsus scores first FDA approval for treatment of red, itchy eyes caused by mites
Tarsus Pharmaceuticals has secured the FDA’s first approval to treat irritated eyes caused by tiny mites, a condition known as demodex blepharitis. The drug, to
July 26, 2023